Just in Time for Summer Sandal Season: Valeant’s Jublia® Approved for Onychomycosis
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
Data presented at the Science of Skin Summit indicate topical regimens and treatments yield visible improvements in laxity, crepiness, and perceived age among individuals taking GLP-1 therapies.